Wealth Alliance Bristol Myers Squibb CO Transaction History

Wealth Alliance

$818 Million
Q3 2024

A detailed history of Wealth Alliance transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Alliance holds 45,739 shares of BMY stock, worth $2.64 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

45,739

Previous 44,503 2.78%

Holding current value

$2.64 Million

Previous $1.85 Million 28.03%

% of portfolio

0.29%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$39.66 - $51.75 $49,019 - $63,963	1,236 Added 2.78%	45,739 $2.37 Million
Q2 2024 Aug 09, 2024	BUY	$40.25 - $52.99 $216,947 - $285,616	5,390 Added 13.78%	44,503 $1.85 Million
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $618,414 - $701,161	12,889 Added 49.15%	39,113 $2.12 Million
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $44,165 - $52,701	-911 Reduced 3.36%	26,224 $1.35 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $65,531 - $73,274	1,132 Added 4.35%	27,135 $1.57 Million
Q2 2023 Aug 02, 2023	BUY	$63.71 - $70.74 $222,284 - $246,811	3,489 Added 15.5%	26,003 $1.66 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $47,836 - $54,257	728 Added 3.34%	22,514 $1.56 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $181,608 - $215,050	-2,652 Reduced 10.85%	21,786 $1.57 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $439 - $259,796	-3,381 Reduced 12.15%	24,438 $1.74 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $89,177 - $98,215	1,228 Added 4.62%	27,819 $2.14 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $461,222 - $553,047	7,502 Added 39.3%	26,591 $1.94 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $435,261 - $507,412	8,116 Added 73.96%	19,089 $1.19 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $83,725 - $98,073	-1,415 Reduced 11.42%	10,973 $649,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $57,390 - $62,498	-927 Reduced 6.96%	12,388 $828,000
Q1 2021 May 18, 2021	SELL	$59.34 - $66.74 $318,715 - $358,460	-5,371 Reduced 28.74%	13,315 $841,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $392,458 - $444,727	6,797 Added 57.17%	18,686 $1.16 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $101,995 - $113,024	1,776 Added 17.56%	11,889 $717,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $82,449 - $96,391	1,504 Added 17.47%	10,113 $595,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $96,233 - $139,849	-2,074 Reduced 19.41%	8,609 $480,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $491,952 - $641,707	9,997 Added 1457.29%	10,683 $686,000
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $33,758 - $44,034	686 New	686 $686,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.

Account